Exercise of Share Options & Voting Rights

RNS Number : 9509K
Venture Life Group PLC
10 May 2022

10 May 2022

Venture Life Group plc

("Venture Life" or the "Company")

Exercise of Share Options & Voting Rights


Venture Life (AIM: VLG), a leading developer, manufacturer and distributer of consumer self-care products, announces that is has issued 666,667 ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares") in accordance with an exercise of employee share options, subject to Admission to trading on AIM.

Application will be made to the London Stock Exchange for the 666,667 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 13 May 2022.

Following Admission, the total number of Ordinary Shares in issue will be 126,498,197 and the total number of voting rights will therefore be 126,498,197. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.


For further information, please contact:

Venture Life Group PLC                                                                            +44 (0) 1344 578004

Jerry Randall, Chief Executive Officer

Daniel Wells, Chief Financial Officer


Cenkos Securities plc (Nomad and Joint Broker)     +44 (0) 20 7397 8900

Stephen Keys / Camilla Hume (Corporate Finance)

Russell Kerr / Michael Johnson (Sales)


Singer Capital Markets (Joint Broker)

Shaun Dobson / Alaina Wong  (Corporate Finance)   +44 (0) 20 74963000

Jonathan Dighe (Sales)



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100